At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Oral Nicotine +2 moredrug
Likely dose
NiQuitinTM Nicotine Lozenge 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product. A Study in Healthy Smokers
In Brief
A clinical study evaluating Oral Nicotine, NiQuitinTM Nicotine Lozenge, and 1 other intervention for Tobacco Dependence. Completed, enrolled 45 participants across 1 site.
Detailed Summary
A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after single-dose of nicotine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Dependence
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
Primary CompletionMay 2009
Study CompletionJun 2009
First PostedMar 2010
TodayJul 2026
First PostedMar 10, 2010
Enrollment StartMar 1, 2009
Primary CompletionMay 1, 2009
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.3 years ago
Interventions
Oral Nicotinedrug
A new l mg oral nicotine product
NiQuitinTM Nicotine Lozengedrug
A marketed 4 mg Nicotine lozenge
Nicorette® Nicotine Gumdrug
A marketed 4 mg Nicotine Gum